Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT04472468
Eligibility Criteria:
Inclusion Criteria:
* Patients with confirmed active malignancy AND,
* Presence of at least moderate (\>10cm) pericardial effusion on CT or Echocardiography
Exclusion Criteria:
* Patients unable to give an informed consent,
* Previous history of open-heart surgery
* Previous history of pericardial window or pericardial instillation of sclerosing therapy.
* Scheduled thoracic or cardiac surgery within the next 3 months
* Patients with contraindications for endovascular procedure such as disseminated intravascular coagulopathy or significant ongoing bleeding tendency, and systemic septicaemia.
* Patient with small or loculated pericardial effusion that is not accessible by subxiphoid approach.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04472468
Study Brief:
Protocol Section:
NCT04472468